In its complaint, BMS alleges that HHS' Health Resources and Services Administration (HRSA), which has responsibility for ...

It will be easier to spread out Part D drug costs over the year, while the total annual cost of medicines will be capped at ...

Health care stocks have underperformed in recent months on uncertainty surrounding the incoming Donald Trump administration, but they can often be a solid defensive play in an uncertain economy.

Pfizer has had its own issues with falling Covid-19 vaccine sales weighing on its stock performance over the recent years.

Prices for the first 10 drugs negotiated by Medicare fell from their initial net prices, but all drugs except one remained ...

Purpose The pharmacology, pharmacokinetics, efficacy, and safety of apixaban are reviewed. Summary Apixaban is an oral, direct, selective factor Xa inhibitor with a rapid onset of action.

The efficacy and safety of apixaban for VTE prophylaxis in major orthopedic surgery have been evaluated in one Phase II trial and three Phase III trials. Traditional treatment of acute VTE entails ...

In the US, buying Eliquis, one of the most popular blood thinning medications, costs over three times more than in the next ...

Bristol Myers Squibb became the latest large drugmaker to sue the federal government over a plan to change how it doles out ...

A new study shows that the US is still behind in controlling the price of prescription drugs. One doctor explains why America ...

and Pfizer's Eliquis (apixaban), an oral anticoagulant, will be the second best-selling drug out of the top ten, with annual sales of $18.7 billion by 2025. “Keytruda is expected to overtake ...